Compared Performance of the 2023 Duke–International Society for Cardiovascular Infectious Diseases, 2000 Modified Duke, and 2015 European Society of Cardiology Criteria for the Diagnosis of Infective Endocarditis in a French Multicenter Prospective Cohort
Clinical Infectious Diseases · 10.04.2024 · 78 (4) · 937-948
DOI: 10.1093/cid/ciae035 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 08.02.2024. Verfasst von Francois Goehringer und 18 weiteren Autor:innen. Beteiligte Einrichtung: Service de maladies infectieuses et tropicales, CHRU de Nancy, Nancy, France. Hauptthemen laut MEDLINE: Endocarditis, Bacterial, Endocarditis, Communicable Diseases, Cardiovascular Diseases. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Background
The 2023 Duke–International Society for Cardiovascular Diseases (ISCVID) criteria for infective endocarditis (IE) were proposed as an updated diagnostic classification of IE. Using an open prospective multicenter cohort of patients treated for IE, we compared the performance of these new criteria to that of the 2000 Modified Duke and 2015 European Society of Cardiology (ESC) criteria.
Methods
Cases of patients treated for IE between January 2017 and October 2022 were adjudicated as certain IE or not. Each case was also categorized as either definite or possible/rejected within each classification. Sensitivity, specificity, and accuracy were estimated with 95% confidence intervals.
Results
Of the 1194 patients analyzed (mean age, 66.1 years; 71.2% males), 414 (34.7%) had a prosthetic valve and 284 (23.8%) had a cardiac implanted electronic device (CIED); 946 (79.2%) were adjudicated as certain IE; 978 (81.9%), 997 (83.5%), and 1057 (88.5%) were classified as definite IE in the 2000 modified Duke, 2015 ESC, and 2023 Duke–ISCVID criteria, respectively. The sensitivity of each set of criteria was 93.2% (95% confidence interval [CI], 91.6–94.8), 95.0% (95% CI, 93.7–96.4), and 97.6% (95% CI, 96.6–98.6), respectively (P < .001 for all 2-by-2 comparisons). Corresponding specificity rates were 61.3% (95% CI, 55.2–67.4), 60.5% (95% CI, 54.4–66.6), and 46.0% (95% CI, 39.8–52.2), respectively. In patients without CIED, sensitivity rates were 94.8% (95% CI, 93.2–96.4), 96.5% (95% CI, 95.1–97.8), and 97.7% (95% CI, 96.6–98.8); specificity rates were 59.0% (95% CI, 51.6–66.3), 56.6% (95% CI, 49.3–64.0), and 53.8% (95% CI, 46.3–61.2), respectively.
Conclusions
Overall, the 2023 Duke–ISCVID criteria had a significantly higher sensitivity but a significantly lower specificity compared with older criteria. This decreased specificity was mainly attributable to patients with CIED.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service de maladies infectieuses et tropicales, CHRU de Nancy, Nancy, France.
- CHRU de Nancy, INSERM, CIC, Epidémiologie Clinique, Université de Lorraine, Nancy, France.
- Département de cardiologie médicale, CHRU de Nancy, CIC-EC, Nancy, France.
- INSERM, BPH, U1219, I-prev/PHARES, CIC 1401, Universite Bordeaux, Bordeaux, France.
- Service de prévention, CHU de Bordeaux, Bordeaux, France.
- Service de maladies infectieuses, CHU de Saint-Etienne, Saint-Etienne, France.
ORCID-Profile: Francois Goehringer, Christine Selton-Suty, François Alla, Amandine Gagneux-Brunon, Pascal Lim, Christophe Tribouilloy, Nelly Agrinier, Bruno Hoen
Zitieren
APA
Goehringer, F., Lalloué, B., Selton-Suty, C., Alla, F., Botelho-Nevers, E., Chirouze, C., Curlier, E., El Hatimi, S., Gagneux-Brunon, A., le Moing, V., Lim, P., Piroth, L., Strady, C., Tribouilloy, C., Virion, J. M., Agrinier, N., Duval, X., Hoen, B., & Association pour l'Etude et la Prévention de l'Endocardite Infectieuse—ObservatoireEI Study Group (2024). Compared Performance of the 2023 Duke–International Society for Cardiovascular Infectious Diseases, 2000 Modified Duke, and 2015 European Society of Cardiology Criteria for the Diagnosis of Infective Endocarditis in a French Multicenter Prospective Cohort. Clinical Infectious Diseases, 78(4), 937-948. https://doi.org/10.1093/cid/ciae035
Vancouver
Goehringer F, Lalloué B, Selton-Suty C, Alla F, Botelho-Nevers E, Chirouze C, et al. Compared Performance of the 2023 Duke–International Society for Cardiovascular Infectious Diseases, 2000 Modified Duke, and 2015 European Society of Cardiology Criteria for the Diagnosis of Infective Endocarditis in a French Multicenter Prospective Cohort. Clinical Infectious Diseases. 2024;78(4):937-948. doi:10.1093/cid/ciae035
BibTeX
@article{Goehringer2024,
author = {Goehringer, Francois and Lalloué, Benoit and Selton-Suty, Christine and Alla, François and Botelho-Nevers, Elisabeth and Chirouze, Catherine and Curlier, Elodie and El Hatimi, Safwane and Gagneux-Brunon, Amandine and le Moing, Vincent and Lim, Pascal and Piroth, Lionel and Strady, Christophe and Tribouilloy, Christophe and Virion, Jean-Marc and Agrinier, Nelly and Duval, Xavier and Hoen, Bruno and Association pour l'Etude et la Prévention de l'Endocardite Infectieuse—ObservatoireEI Study Group, Association pour l'Etude et la Prévention de l'Endocardite Infectieuse—ObservatoireEI Study Group},
title = {Compared Performance of the 2023 Duke–International Society for Cardiovascular Infectious Diseases, 2000 Modified Duke, and 2015 European Society of Cardiology Criteria for the Diagnosis of Infective Endocarditis in a French Multicenter Prospective Cohort},
journal = {Clinical Infectious Diseases},
year = {2024},
volume = {78},
number = {4},
pages = {937--948},
doi = {10.1093/cid/ciae035}
}
EUVIMED